Since 2007, Kevin Outterson has been an associate professor at Boston University School of Law, where he teaches courses in health care, business law, and globalization. Prior to joining the faculty at Boston University, he served as Associate Professor of Law at West Virginia University.

His research focuses on global pharmaceutical markets and health disparities. In the realm of pharmaceutical patent law, he works to achieve equitable access without harming innovation incentives. He does so through scholarship that bridges the gap between drug companies and low-income populations. He publishes in both legal journals (Yale Journal of Health Policy, Law & Ethics, Cardozo Law Review, University of Pittsburgh Law Review, Kansas Law Review, and American Journal of Law & Medicine) and peer-reviewed medical and health policy journals (Health Affairs, Lancet Infectious Diseases, Environmental Philosophy, Medical Journal of Australia, and Journal of Generic Medicines). His academic papers can be found at www.ssrn.com.

In addition, he has testified on pharmaceutical marketing issues before legislative and regulatory bodies in several states. At the federal level, he has testified before the US Senate Committee on Health, Education, Labor, & Pensions on global drug pricing and submitted testimony to USTR regarding compulsory licensing of drugs by Brazil and Thailand. Outterson recently served as a speaker on global pharmaceutical intellectual property issues for WIPO and WHO. His other academic work focuses on health disparities, especially racial and linguistic disparities in health.

Outterson worked as an associate and then a partner in two major US law firms for more than a decade. His practice included health care transactions domestically, as well as tax and corporate issues for nonprofit health systems and international businesses.